The HSPB1 Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the A-549 human lung adenocarcinoma cell line. This polyclonal pool provides a heterogeneous gene-disrupted model suitable for loss-of-function studies of HSPB1, avoiding artifacts associated with clonal selection. It enables robust functional genomics, target validation, and pathway analysis in a lung cancer context.
The A-549 cell line, established from an alveolar basal epithelial adenocarcinoma, is a widely used model for lung adenocarcinoma and alveolar type II pneumocyte biology. Its epithelial origin and well-characterized mutational profile make it ideal for investigating oncogenic signaling, stress responses, and therapeutic resistance mechanisms.
HSPB1 encodes the small heat shock protein HSP27, which functions as an ATP-independent molecular chaperone preventing protein aggregation and regulating actin cytoskeleton dynamics. Under stress conditions, p38 MAPK activates MAPKAPK2, leading to phosphorylation of HSPB1 and a shift from large oligomers to dimers. Phosphorylated HSPB1 stabilizes actin filaments and sequesters pro-apoptotic factors including cytochrome c and caspase-3, thereby blocking apoptosis. HSPB1 interacts with CRYAB, HSPB6, HSP70, and Daxx, and modulates NF-??B and Akt signaling. Upstream regulators include heat shock, oxidative stress, TNF-??, IL-1, and HSF1, integrating diverse stress inputs to control cell survival and migration.
In the A-549 lung adenocarcinoma background, HSPB1 contributes to stress adaptation, apoptosis evasion, and cell motility, processes critical for tumor progression and drug resistance. Disruption of HSPB1 in this model allows dissection of its protective roles in MAPK pathway signaling and actin reorganization. The polyclonal knockout format captures heterogeneous responses, making it valuable for studying compensatory mechanisms and population-level effects upon HSPB1 loss.
This knockout cell population supports a range of assays including western blotting for total and phospho-HSPB1, RT-qPCR, immunofluorescence, Annexin V/PI apoptosis assays, scratch wound migration assays, and MTT drug sensitivity testing. Applications encompass investigation of lung cancer stress biology, anti-apoptotic mechanisms, cell migration, and chemoresistance. It is suitable for functional genomics and target validation campaigns. For further information, please contact Ascent Research.
